Jeffrey A Bogart, MD

Jeffrey A Bogart, MD
Appointed 07/01/90
Women's Health Network
619 Upstate University Hospital - Downtown Campus
750 East Adams Street
Syracuse, NY 13210

315 464-5276

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Upstate Cancer Center: Radiation Oncology
  • Women's Health Network: Breast Care

Research Programs and Affiliations

  • Cancer Research Institute
  • Radiation Oncology


Education & Fellowships

  • Residency: University Hospital, SUNY Health Science Center at Syracuse, 1993, Radiation Oncology
  • Residency: University of Maryland Medical Systems, 1990, Internal Medicine
  • MD: SUNY Health Science Center at Syracuse, 1989

Clinical Interests

  • Lung cancer
  • Prostate cancer including IMRT and brachytherapy
  • Breast cancer
  • Lymphoma
  • Pediatric oncology

Research Interests

  • Lung and prostate cancer
  • Clinical investigations through cooperative clinical trials
  • Chair: CALGB Radiation Oncology Committee

Clinical Trials

  • AbbVie Protocol M14-360 - A Phase 1 Dose Escalation and Phase 2 Randomized,Placebo-Controlled Study of the Efficacy and Tolerability of Veliparib in Combination with Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Subjects with Stage III Non-Small Cell Lung Cancer (NSCLC)
    Read more
  • CALGB 30610: Phase III Comparison of Thoracic Radiotherapy Regimens in patients with Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide.
    Read more
  • RTOG 0534 -A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with Rising PSA After Radical Prostatectomy
    Read more
  • RTOG 0839: Randomized Phase II Study of Pre-operative Chemoradiotherapy +/- Panitumumab (IND #110152) Followed by Consolidation Chemotherapy +/- Cetuximab in Potentially Operable Locally Advanced (Stage IIIA, N2+) Non-Small Cell Lung Cancer
    Read more
  • RTOG 0937 - Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
    Read more

Specialties & Certification

  • Radiation Oncology

Diseases & Conditions Treated

  • All Cancers and Hematological Conditions
  • Esophageal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Urologic Cancers


  • Adults and Children


  • Gamma Knife Radiosurgery
  • Image Guided Radiation Therapy (IGRT)
  • Intensity Modulated Radiation Therapy (IMRT)
  • Internal Radiation
  • Mammosite Brachytherapy
  • Prostate Brachytherapy
  • Radiation Therapy
  • Stereotactic Body Radiation Therapy (SBRT)
  • Total Skin Irradiation


  • American College of Radiology (ACR)
  • Onondaga County Medical Society

Current Hospital Privileges

  • Upstate University Hospital
  • Crouse Hospital
  • St. Joseph's Hospital Health Center
  • VA Medical Center

HealthLinkOnAir Radio Interview

6/18/14 Advanced radiotherapy coming to the new Upstate Cancer Center

8/12/12 New study for the treatment of prostate cancer


Link to PubMed External Icon (Opens new window. Close the PubMed window to return to this page.)

Research Abstract

Video Assisted Wedge Resection (VAR) and Radiotherapy for High Risk T1 Non-Small Cell Lung Cancer: A CALGB Phase II Study. With H. Shennib, H. Kreisman, L. Kohman, D. Sugarbaker, M. Green, J. Herndon

This national cooperative group study seeks to evaluate the role of local radiotherapy after thoracoscopic wedge resection in non-small cell carcinoma. Participating patients are required to have poor pulmonary function placing them at high risk for complications with a standard open thoracotomy approach. As a higher incidence of local recurrence is recognized to be an important cause of failure of limited resections through thoracotomy, and is likely to become more pronounced with the new technique of VAR, and, since locoregional recurrence constitutes at least 50% of the comorbid terminal events in patients who die from lung cancer following resection, it would appear pertinent to explore the role of radiotherapy as an adjuvant to wedge resection, particularly through VAR, of peripheral T1-NSCLC.

Clinical Profile Shortcut:
Faculty Profile Shortcut:

Return to Previous Page || Search Again